Profile
Sector:
HealthcareIndustry:
Medical DevicesCountry:
United StatesIPO:
12 November 1992Website:
http://www.biolase.comNext earnings report:
N/ALast dividends:
24 June 2005Next dividends:
N/APrice
regular market | Thu, 21 Nov 2024 14:30:00 GMTDividend
Analysts recommendations
Institutional Ownership
BIOL Latest News
LAKE FOREST, CA / ACCESSWIRE / October 1, 2024 / BIOLASE, Inc. (NASDAQ:BIOL) (the "Company"), a global leader in dental lasers, today announced that the Company and its direct domestic subsidiaries have voluntarily initiated Chapter 11 proceedings (the "Bankruptcy Petitions") in the United States Bankruptcy Court for the District of Delaware (the "Court"). BIOLASE will seek Court approval to continue operating during the proceedings and remains focused on providing its customers with its award-winning dental lasers and customer service.
LAKE FOREST, CA / ACCESSWIRE / August 8, 2024 / BIOLASE, Inc. (NASDAQ:BIOL), a leader in dental laser technology, today reported its financial results for the second quarter ended June 30, 2024. "We experienced another strong quarter in consumable revenue, recording our second-highest mark ever and achieving over 600 recurring subscriptions," commented John Beaver, President and Chief Executive Officer of BIOLASE.
BIOLASE, Inc. (NASDAQ: BIOL) Q1 2024 Earnings Conference Call on May 13, 2024 at 4:30 PM ET. Company representatives include Michael Polyviou, John Beaver, and Jennifer Bright. Conference call participants include Bruce Jackson and Ed Woo. Operator will begin the call in a listen-only mode.
LAKE FOREST, CA / ACCESSWIRE / March 14, 2024 / BIOLASE, Inc. (NASDAQ:BIOL), the globally recognized leader in dental laser technology, today announced that it will release fourth quarter and full year 2023 financial and operating results on Thursday, March 21, 2024, after the close of the U.S. financial markets and will host a conference call and webcast that day at 4:30 p.m. ET / 1:30 p.m.
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Biolase (NASDAQ: BIOL ) stock is taking a beating on Friday following the release of its earnings report for the first quarter of 2023. The bad news for investors in BIOL stock is the company's earnings per share of -18 cents for the period.
BIOLASE, Inc. (NASDAQ:BIOL ) Q4 2022 Earnings Conference Call March 28, 2023 4:30 PM ET Company Participants Todd Kehrli - IR John Beaver - President and CEO Jennifer Bright - CFO Conference Call Participants Bruce Jackson - The Benchmark Company Frank Takkinen - Lake Street Capital Markets Anthony Vendetti - Maxim Group Edward Woo - Ascendiant Capital Operator Greetings. Welcome to the BIOLASE 2022 Fourth Quarter and Full Year Financial Results Call.
What type of business is BIOLASE?
BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. The company offers Waterlase all-tissue dental laser systems for cutting soft and hard tissues; diode soft-tissue laser systems for soft tissue, hygiene, temporary pain relief, teeth whitening, and cosmetic procedures; and Epic Hygiene laser to manage non-surgical periodontitis and enhance clinical production. It also manufactures and sells consumable products and accessories for its laser systems, as well as markets flexible fibers and hand pieces; and sells teeth whitening gel kits. The company sells its products through its field sales force and distributor network. The company was formerly known as BIOLASE Technology, Inc. and changed its name to BIOLASE, Inc. in 2012. BIOLASE, Inc. was founded in 1984 and is headquartered in Foothill Ranch, California. On October 1, 2024, BIOLASE, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
What sector is BIOLASE in?
BIOLASE is in the Healthcare sector
What industry is BIOLASE in?
BIOLASE is in the Medical Devices industry
What country is BIOLASE from?
BIOLASE is headquartered in United States
When did BIOLASE go public?
BIOLASE initial public offering (IPO) was on 12 November 1992
What is BIOLASE website?
https://www.biolase.com
Is BIOLASE in the S&P 500?
No, BIOLASE is not included in the S&P 500 index
Is BIOLASE in the NASDAQ 100?
No, BIOLASE is not included in the NASDAQ 100 index
Is BIOLASE in the Dow Jones?
No, BIOLASE is not included in the Dow Jones index
When was BIOLASE the previous earnings report?
No data
When does BIOLASE earnings report?
Next earnings report date is not announced yet